MCID: CHR070
MIFTS: 43

Chronic Inflammatory Demyelinating Polyradiculoneuropathy malady

Categories: Neuronal diseases

Aliases & Classifications for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Aliases & Descriptions for Chronic Inflammatory Demyelinating Polyradiculoneuropathy:

Name: Chronic Inflammatory Demyelinating Polyradiculoneuropathy 12 14
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 69
Polyradiculoneuropathy Chronic Inflammatory Demyelinating 52

Classifications:



External Ids:

Disease Ontology 12 DOID:5213
ICD10 33 G61.81
ICD9CM 35 357.81
MeSH 42 D020277
NCIt 47 C84636
SNOMED-CT 64 128209004 444728005
UMLS 69 C0393819

Summaries for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

MalaCards based summary : Chronic Inflammatory Demyelinating Polyradiculoneuropathy, also known as polyradiculoneuropathy, chronic inflammatory demyelinating, is related to chronic inflammatory demyelinating polyneuropathy and chronic inflammatory demyelinating polyneuritis. An important gene associated with Chronic Inflammatory Demyelinating Polyradiculoneuropathy is MPZ (Myelin Protein Zero), and among its related pathways/superpathways are Allograft rejection and NF-kappaB Signaling. The drugs Immunoglobulins and gamma-Globulins have been mentioned in the context of this disorder. Affiliated tissues include spinal cord, t cells and skin, and related phenotypes are cellular and homeostasis/metabolism

Related Diseases for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Diseases related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 113)
id Related Disease Score Top Affiliating Genes
1 chronic inflammatory demyelinating polyneuropathy 11.9
2 chronic inflammatory demyelinating polyneuritis 11.2
3 polyradiculoneuropathy 11.1
4 neuropathy 10.3
5 hereditary type 2 neuropathy 10.3 MPZ PMP22
6 chrna1-related congenital myasthenic syndrome 10.3 MPZ PMP22
7 surfactant metabolism dysfunction, pulmonary, 2 10.3 MPZ PMP22
8 hypertonia 10.3 MPZ PMP22
9 pneumonic plague 10.3 MPZ PMP22
10 deafness, autosomal recessive 76 10.3 MPZ PMP22
11 classic galactosemia and clinical variant galactosemia 10.3 MPZ PMP22
12 hypertrophic osteoarthropathy, primary, autosomal recessive 2 10.3 MPZ PMP22
13 neuropathy, inflammatory demyelinating 10.3 MPZ PMP22
14 acute sanguinous otitis media 10.3 MPZ PMP22
15 dejerine-sottas disease 10.3 MPZ PMP22
16 nephrolithiasis, uric acid 10.2 MPZ PMP22
17 chkb-related muscle diseases 10.2 MPZ PMP22
18 infantile epileptic encephalopathy 10.2 MPZ PMP22
19 potocki-lupski syndrome 10.2 MPZ PMP22
20 pituitary adenoma, prolactin-secreting 10.2 MPZ PMP22
21 ciliary discoordination, due to random ciliary orientation 10.2 ALB IFNG
22 multifocal motor neuropathy 10.2
23 aniseikonia 10.2 IFNG IL17A
24 rosacea 10.2 ALB IFNG
25 ovarian papillary cystadenoma 10.2 ALB IFNG
26 parkinson disease 11 10.2 IFNG IL17A
27 lipid metabolism disorder 10.2 IFNB1 IFNG
28 inhalation anthrax 10.2 ALB IL17A
29 polyarteritis nodosa 10.2 IFNG IL17A
30 hypertropia 10.2 ALB IFNG
31 hereditary alpha tryptasemia syndrome 10.2 ALB IFNG
32 systemic lupus erythematosus 10.2
33 lupus erythematosus 10.2
34 turner syndrome 10.1 IFNB1 IL17A
35 rickets due to defect in vitamin d 25-hydroxylation 10.1 MBP MPZ
36 isolated growth hormone deficiency 10.1 ALB IFNG
37 benign deep fibrous histiocytoma 10.1 ALB IFNG
38 periventricular leukomalacia 10.1 IFNG IL17A
39 uterine ligament serous adenocarcinoma 10.1 ALB MPZ PMP22
40 plummer's disease 10.1 ALB IFNG
41 aortic valve prolapse 10.1 ALB PMP22
42 denys-drash syndrome 10.1 IFNG IL17A
43 vulvar sarcoma 10.1 ALB MBP
44 cervicitis 10.1
45 crest syndrome 10.1 IFNB1 MBP
46 orbital osteomyelitis 10.1 IFNG IL17A
47 trichomalacia 10.1 IL17A MBP
48 gastric dilatation 10.1 IL17A MBP
49 foodborne botulism 10.1 ALB IFNG IL17A
50 uterine ligament clear cell adenocarcinoma 10.1 ALB IFNG IL17A

Graphical network of the top 20 diseases related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy:



Diseases related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Symptoms & Phenotypes for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

MGI Mouse Phenotypes related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.98 ALB CXCR4 IFNG MBP MPZ PMP22
2 homeostasis/metabolism MP:0005376 9.97 ALB CXCR4 IFNB1 IFNG IL17A MBP
3 hematopoietic system MP:0005397 9.95 CXCR4 IFNB1 IFNG IL17A MBP MPZ
4 immune system MP:0005387 9.87 MBP MPZ PRF1 CXCR4 IFNB1 IFNG
5 mortality/aging MP:0010768 9.86 ALB CXCR4 IFNG IL17A MBP MPZ
6 neoplasm MP:0002006 9.55 PRF1 ALB CXCR4 IFNB1 IFNG
7 nervous system MP:0003631 9.5 CXCR4 IFNB1 IFNG MBP MPZ PMP22
8 reproductive system MP:0005389 9.1 CXCR4 IFNG MBP MPZ PMP22 PRF1

Drugs & Therapeutics for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Drugs for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 43)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1 Immunoglobulins Phase 4,Phase 3,Phase 2,Phase 1
2 gamma-Globulins Phase 4,Phase 3,Phase 2
3 Immunoglobulins, Intravenous Phase 4,Phase 3,Phase 2
4 Rho(D) Immune Globulin Phase 4,Phase 3,Phase 2
5 Antibodies Phase 4,Phase 3,Phase 2,Phase 1
6
Prednisone Approved, Vet_approved Phase 3 53-03-2 5865
7
Mycophenolic acid Approved Phase 3 24280-93-1 446541
8
Mycophenolate mofetil Approved, Investigational Phase 3 128794-94-5 5281078
9
Benzocaine Approved Phase 3 1994-09-7, 94-09-7 2337
10
Glycine Approved, Nutraceutical, Vet_approved Phase 3 56-40-6 750
11 tannic acid Approved, Nutraceutical Phase 3
12 glucocorticoids Phase 3
13 Hormone Antagonists Phase 3,Phase 2
14 Hormones Phase 3,Phase 2
15 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2
16 Immunoglobulin G Phase 3
17 Potassium Channel Blockers Phase 3
18 3,4-diaminopyridine Phase 3
19 Immunosuppressive Agents Phase 3,Phase 2
20 Fingolimod Hydrochloride Phase 3
21 Anti-Inflammatory Agents Phase 3
22 Antineoplastic Agents, Hormonal Phase 3
23 Pharmaceutical Solutions Phase 3,Phase 2
24 Anti-Bacterial Agents Phase 3
25 Antibiotics, Antitubercular Phase 3
26
Interferon beta-1a Approved, Investigational Phase 2 145258-61-3 6438354
27
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
28 interferons Phase 2
29 Adjuvants, Immunologic Phase 2
30 Thioctic Acid Phase 2
31 Trace Elements Phase 2
32 Vitamin B Complex Phase 2
33 Vitamins Phase 2
34 Anti-Infective Agents Phase 2
35 Protective Agents Phase 2
36 Interferon-beta Phase 2
37 Micronutrients Phase 2
38 Antiviral Agents Phase 2
39 Antioxidants Phase 2
40 Folate Nutraceutical Phase 2
41 Alpha-lipoic Acid Nutraceutical Phase 2
42 Vitamin B9 Nutraceutical Phase 2
43 Antibodies, Anti-Idiotypic

Interventional clinical trials:

(show all 42)
id Name Status NCT ID Phase
1 IVIg for Demyelination in Diabetes Mellitus Recruiting NCT02372149 Phase 4
2 Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD) Withdrawn NCT01757574 Phase 4
3 Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients. Completed NCT01625182 Phase 3
4 Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. Completed NCT01824251 Phase 3
5 Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy Completed NCT01184846 Phase 3
6 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) Completed NCT01545076 Phase 3
7 Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Completed NCT00220740 Phase 3
8 Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy Completed NCT00004772 Phase 3
9 Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg Completed NCT01349270 Phase 3
10 Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy Completed NCT00004286 Phase 3
11 Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy Completed NCT00004939 Phase 3
12 Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP Recruiting NCT02955355 Phase 3
13 Efficacy and Safety Study of I10E in Treatment of Patients With CIDP Recruiting NCT02293460 Phase 3
14 Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302 Recruiting NCT02317562 Phase 3
15 Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP Recruiting NCT02549170 Phase 3
16 Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Active, not recruiting NCT02027701 Phase 3
17 Interest of Mycophenolate for CIDP Weaning Active, not recruiting NCT02494505 Phase 3
18 Panzyga in CIDP Administered at Different Infusion Rates Not yet recruiting NCT03166527 Phase 3
19 Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) Neuropathy Not yet recruiting NCT02638207 Phase 3
20 Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP Terminated NCT01225276 Phase 2, Phase 3
21 Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Completed NCT00099489 Phase 2
22 Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Completed NCT01017159 Phase 2
23 Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy Completed NCT00962429 Phase 2
24 Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Completed NCT00001287 Phase 2
25 Stem Cell Transplantation for Stiff Person Syndrome (SPS) Recruiting NCT02282514 Phase 1, Phase 2
26 SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study Recruiting NCT02967679 Phase 1, Phase 2
27 Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy Active, not recruiting NCT00278629 Phase 2
28 High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy Withdrawn NCT01236456 Phase 2
29 Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy Withdrawn NCT02574962 Phase 2
30 Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy Unknown status NCT01379833
31 MRI in Diagnosing and Monitoring CIDP Completed NCT02017769
32 Study of CIDP Patients During IVIG Treatment Completed NCT00305266
33 Effect of Resistance and Aerobic Exercise in CIDP or MMN Completed NCT02121678
34 Immunoglobulin Dosage and Administration Form in CIDP and MMN Completed NCT02111590
35 Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy Completed NCT01847937
36 Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Recruiting NCT02629796
37 Transcriptome Analysis of the Peripheral Blood in CIDP Recruiting NCT02404298
38 Subcutaneous Immunoglobulin for CIDP Recruiting NCT02465359
39 IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements Recruiting NCT02414490
40 sCD163 & CD19 as Candidate Biomarkers in CIDP and MMN Recruiting NCT02271724
41 Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin Not yet recruiting NCT02892890
42 Descriptive Analysis of Morphological Aspects of Nerve by Ultra-high Frequency Ultrasound (30-50MHZ) in Demyelinating Neuropathies: Inflammatory Demyelinating Polyneuropathy Chronic (IPDC), Neuropathy Multifocal Motor Block of Conducting (NMMBC) and Neuro Not yet recruiting NCT03008733

Search NIH Clinical Center for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Genetic Tests for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Anatomical Context for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

MalaCards organs/tissues related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy:

39
Spinal Cord, T Cells, Skin, Tongue, Brain, Thyroid, Nk Cells

Publications for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Articles related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy:

(show top 50) (show all 305)
id Title Authors Year
1
Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. ( 28084646 )
2017
2
Intravenous Immunoglobulins Lower Inflammatory Gene Expression in Skin Biopsies of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients. ( 27286956 )
2016
3
Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy. ( 27211560 )
2016
4
A case of chronic inflammatory demyelinating polyradiculoneuropathy after treatment with pegylated interferon I+-2a in a patient with chronic hepatitis B virus infection. ( 27680223 )
2016
5
Fatigue, Pain, Anxiety and Depression in Guillain-BarrAc Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy. ( 27077919 )
2016
6
A case of a 17-year-old male with neurofascin-155 antibody-positive chronic inflammatory demyelinating polyradiculoneuropathy presenting with tremor and ataxia. ( 27580761 )
2016
7
Chronic inflammatory demyelinating polyradiculoneuropathy: A new animal model for new therapeutic targets. ( 27838091 )
2016
8
Stance Postural Strategies in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy. ( 26977594 )
2016
9
Cerebral infarction following subcutaneous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. ( 26873805 )
2016
10
A Bodybuilder With Weak Hands and Feet: Corticosteroid-Responsive Pure Motor Chronic Inflammatory Demyelinating Polyradiculoneuropathy Following Anabolic Steroid Use. ( 27438336 )
2016
11
IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay. ( 27852440 )
2016
12
Motor unit number index (MUNIX): Is it relevant in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)? ( 26750580 )
2016
13
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies. ( 27902997 )
2016
14
Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand. ( 27113227 )
2016
15
Peripheral Nerve Ultrasonography in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: Correlations with Clinical and Neurophysiological Data. ( 27313890 )
2016
16
Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. ( 27781132 )
2016
17
Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop. ( 27241239 )
2016
18
Improving the management of chronic inflammatory demyelinating polyradiculoneuropathy. ( 27230584 )
2016
19
Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-BarrAc syndrome: a case report. ( 27380808 )
2016
20
Transcriptome Analysis of Peripheral Blood in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients Identifies TNFR1 and TLR Pathways in the IVIg Response. ( 27175635 )
2016
21
A case of severe chronic inflammatory demyelinating polyradiculoneuropathy with monoclonal gammopathy of undetermined significance with alternating immunoglobulin class to IgM from IgA. ( 27580763 )
2016
22
Multiple Myeloma Associated Chronic Inflammatory Demyelinating Polyradiculoneuropathy: The Importance of Continued Surveillance. ( 28070468 )
2016
23
Triple-stimulation technique improves the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy. ( 25571892 )
2015
24
Relapse with Dysphagia in a Case of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. ( 26179538 )
2015
25
Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. ( 25677463 )
2015
26
Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. ( 26305459 )
2015
27
Steroids for chronic inflammatory demyelinating polyradiculoneuropathy: evidence base and clinical practice. ( 26437234 )
2015
28
Which criteria for research in chronic inflammatory demyelinating polyradiculoneuropathy? an analysis of current practice. ( 25354388 )
2015
29
Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies. ( 26392214 )
2015
30
The diagnostic value of MRI in pediatric chronic inflammatory demyelinating polyradiculoneuropathy. ( 25972306 )
2015
31
Chronic inflammatory demyelinating polyradiculoneuropathy with cranial nerves hypertrophy, thyroid-related orbitopathy and IgG monoclonal gammopathy: a case report. ( 25647292 )
2015
32
Chronic inflammatory demyelinating polyradiculoneuropathy with cholesterol deposits in a dog. ( 26450833 )
2015
33
New insights into the management of chronic inflammatory demyelinating polyradiculoneuropathy. ( 26107324 )
2015
34
Long-term Immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. ( 25556954 )
2015
35
Update on the treatment of chronic inflammatory demyelinating polyradiculoneuropathy. ( 26203970 )
2015
36
The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in pathogenesis. ( 26198918 )
2015
37
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. ( 25561247 )
2015
38
Characteristic MRI features of chronic inflammatory demyelinating polyradiculoneuropathy. ( 25687202 )
2015
39
Maintenace therapy in chronic inflammatory demyelinating polyradiculoneuropathy. ( 26088325 )
2015
40
Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypes. ( 25105500 )
2014
41
Intravenous immunoglobulin response in treatment-naA^ve chronic inflammatory demyelinating polyradiculoneuropathy. ( 25515502 )
2014
42
Challenges in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy. ( 25200479 )
2014
43
Spinal cord involvement in chronic inflammatory demyelinating polyradiculoneuropathy: a clinical and MRI study. ( 24988899 )
2014
44
Variations of the perforin gene in patients with chronic inflammatory demyelinating polyradiculoneuropathy. ( 25354579 )
2014
45
Genetics of Guillain-BarrAc syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions. ( 25039604 )
2014
46
Somatosensory evoked potentials in chronic inflammatory demyelinating polyradiculoneuropathy. ( 24887608 )
2014
47
Ophthalmic nerve hypertrophy in chronic inflammatory demyelinating polyradiculoneuropathy. ( 24778284 )
2014
48
Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go. ( 24612201 )
2014
49
Progressive bilateral ptosis in a patient with midbrain metastasis and chronic inflammatory demyelinating polyradiculoneuropathy. ( 24594646 )
2014
50
Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review. ( 24507546 )
2014

Variations for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Expression for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Search GEO for disease gene expression data for Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Pathways for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

GO Terms for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Cellular components related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 myelin sheath GO:0043209 8.8 ALB MBP MPZ

Biological processes related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy according to GeneCards Suite gene sharing:

(show all 11)
id Name GO ID Score Top Affiliating Genes
1 apoptotic process GO:0006915 9.8 CXCR4 IFNG IL17A PRF1
2 chemical synaptic transmission GO:0007268 9.63 MBP MPZ PMP22
3 defense response to virus GO:0051607 9.61 IFNB1 IFNG PRF1
4 cell death GO:0008219 9.48 IL17A PMP22
5 response to virus GO:0009615 9.43 CXCR4 IFNB1 IFNG
6 positive regulation of peptidyl-serine phosphorylation of STAT protein GO:0033141 9.4 IFNB1 IFNG
7 positive regulation of osteoclast differentiation GO:0045672 9.37 IFNG IL17A
8 positive regulation of interleukin-6 secretion GO:2000778 9.32 IL17A MBP
9 positive regulation of interleukin-23 production GO:0032747 9.16 IFNG IL17A
10 positive regulation of killing of cells of other organism GO:0051712 8.96 IFNG PRF1
11 myelination GO:0042552 8.8 MBP MPZ PMP22

Molecular functions related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 8.8 IFNB1 IFNG IL17A

Sources for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....